CAR-T Meeting 2023 | The importance of addressing inequalities in access to CAR-T therapy & the role of the MDT
Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, shares some insights into the importance of addressing the challenge of inequalities in access to CAR-T therapy from a European perspective, highlighting other examples of this issue in hematological malignancies. Prof. Chabannon also comments on the role of multidisciplinary team (MDT) in addressing this issue. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
BELLICUM PHARMACEUTICALS: Membership on an entity’s Board of Directors or advisory committees
BMS/CELGENE: Speakers Bureau, Membership on an entity’s Board of Directors or advisory committees
EBMT: Membership on an entity’s Board of Directors or advisory committees
FRESENIUS KABI: Research Funding
KITE/GILEAD: Honoraria, Speakers Bureau, Membership on an entity’s Board of Directors or advisory committees
JANSSEN PHARMACEUTICALS: Membership on an entity’s Board of Directors or advisory committees
JAZZ: Honoraria
MILTENYI BIOTECH: Research Funding
NOVARTIS: Speakers Bureau
SANOFI SA: Speakers Bureau, Honoraria, Research Funding
TERUMO BCT: Speakers Bureau
